BioSpace News Archive

TISSIUM, a privately-owned life science company developing fully synthetic, biomorphic programmable polymers, announced it has been named a French Tech 120 company.

Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatment options, today announced the company will host a panel discussion and luncheon at the Annual World Stem Cell Summit in Miami from January 21 – 24, 2020.

What do the Columbia Center in Seattle, Capella Tower in Minneapolis and Salesforce Tower in San Francisco have in common? They are all iconic buildings with 1,000 or more steps, and they are sites for The Leukemia & Lymphoma Society’s latest fundraising innovation – BIG CLIMB.

Medtronic plc (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval of Micra™ AV, the world’s smallest pacemaker with atrioventricular (AV) synchrony.

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, today announced the first installation of its new EOSedge™ system in North America at CHU Sainte-Justine Mother and Child University Hospital Centre in Montreal, Quebec, Canada.

Eli Lilly and Company (NYSE: LLY), a global healthcare and biopharmaceutical company, will invest over $470 million and create more than 460 new jobs in Durham, Governor Roy Cooper announced today.

The Ahmanson Foundation Fracture Center is the Latest Phase of OIC’s Reimagined Campus Envisioning What Pediatric Medical Care Should Look Like in the 21st Century

Funded in Part by Generous Community Members, Expansion Will Help Meet Demand for Expert Heart Care [21-January-2020] MORRISTOWN, N.J. , Jan. 21, 2020 /PRNewswire/ -- Atlantic Health System’s Morristown Medical Center, nationally recognized for heart care, today opened the second of two new 36-bed units for patients with heart disease, completing a two-story expansion

Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Fourth Quarter 2019 Financial Results on Thursday, February 6, 2020, at 4:30pm Eastern Time.

CytoSeek Ltd, a discovery-stage biotech company developing the next generation of cell therapies to treat cancer using its pioneering cell-membrane augmentation technology, announces today [20 Jan] the appointment of Dr Carolyn Porter as Chief Executive Officer and a Director of the company.